[8] Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer[J].Clin Oncol,2008,26(8):1275-1281.ª¤

    [9] Keam B,Im SA,Kim HJ,et al. Prognostic impact of clinicopat hologic parameters in stage¢ò/¢óbreast cancer treated wit hneoadjuvant docetaxel and doxorubicin chemot herapy : paradoxical features of t he triple negative breast cancer[J].BMC Cancer,2007,7:203.ª¤ ......